Lund Melanoma Study Group
101 – 110 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
- Contribution to journal › Article
-
Mark
The human melanoma proteome atlas-Defining the molecular pathology
- Contribution to journal › Article
-
Mark
Surgery of metastatic melanoma after systemic therapy–the SUMMIST trial : study protocol for a randomized controlled trial
- Contribution to journal › Letter
- 2020
-
Mark
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma
- Contribution to journal › Article
-
Mark
Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease
- Contribution to journal › Article
-
Mark
Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- Contribution to journal › Article
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
- Contribution to journal › Scientific review
-
Mark
Desloratadine and loratadine use associated with improved melanoma survival
- Contribution to journal › Letter
-
Mark
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
- Contribution to journal › Article
